EP 3548604 A1 20191009 - MODIFIED PEPTIDES
Title (en)
MODIFIED PEPTIDES
Title (de)
MODIFIZIERTE PEPTIDE
Title (fr)
PEPTIDES MODIFIÉS
Publication
Application
Priority
- IB 2016057193 W 20161130
- IB 2017057513 W 20171130
Abstract (en)
[origin: WO2018100516A1] The present invention relates to the field of antimicrobial agents. In particular, the present invention relates to polypeptides comprising the sequence of a peptidoglycan hydrolase and a peptide sequence heterologous to the peptidoglycan hydrolase wherein said heterologous peptide sequence comprises a specific sequence motif which is 16, 17, 18, 19 or 20 amino acids in length. The present invention relates also to corresponding nucleic acids, vectors, bacteriophages, host cells, compositions and kits. The present inventions also relates to the use of said polypeptides, nucleic acids, vectors, bacteriophages, host cells, compositions and kits in methods for treatment of the human or animal body by surgery or therapy or in diagnostic methods practiced on the human or animal body. The polypeptides, nucleic acids, vectors, bacteriophages, host cells, compositions and kits according to the invention may also be used as an antimicrobial in, e.g., food or feed, in cosmetics, or as disinfecting agent.
IPC 8 full level
C12N 1/06 (2006.01)
CPC (source: EP KR US)
A23K 20/147 (2016.05 - KR); A23K 20/195 (2016.05 - KR); A23L 3/3463 (2013.01 - KR); A23L 3/34635 (2013.01 - EP KR US); A61K 8/64 (2013.01 - KR); A61L 2/18 (2013.01 - KR); A61P 31/04 (2017.12 - EP KR); A61Q 19/00 (2013.01 - KR); C07K 7/08 (2013.01 - EP KR US); C07K 14/005 (2013.01 - EP KR); C07K 14/3156 (2013.01 - US); C07K 14/43563 (2013.01 - EP KR); C07K 14/461 (2013.01 - EP KR); C07K 14/463 (2013.01 - EP KR); C07K 14/4723 (2013.01 - EP KR US); C11D 3/38636 (2013.01 - EP KR US); C11D 3/48 (2013.01 - EP KR US); C12N 7/00 (2013.01 - EP KR); C12N 9/14 (2013.01 - EP KR); C12N 9/2462 (2013.01 - EP KR US); A61K 38/00 (2013.01 - EP KR US); A61K 2800/524 (2013.01 - KR); A61L 2/18 (2013.01 - EP); C07K 2319/00 (2013.01 - EP KR); C07K 2319/55 (2013.01 - EP KR US); C12N 2795/10122 (2013.01 - EP KR US); C12N 2795/10131 (2013.01 - EP KR); C12N 2795/10133 (2013.01 - EP KR)
Citation (search report)
See references of WO 2018100516A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018100516 A1 20180607; AU 2017367293 A1 20190530; AU 2017367293 B2 20231102; CA 3044165 A1 20180607; CN 110036105 A 20190719; CN 110036105 B 20240109; EA 201991015 A1 20191230; EP 3548604 A1 20191009; IL 266996 A 20190731; JP 2020500535 A 20200116; JP 2023052138 A 20230411; KR 102573154 B1 20230901; KR 20190085549 A 20190718; MX 2019005979 A 20191128; US 11161883 B2 20211102; US 2019337997 A1 20191107; US 2022089657 A1 20220324; WO 2018100408 A1 20180607
DOCDB simple family (application)
IB 2017057513 W 20171130; AU 2017367293 A 20171130; CA 3044165 A 20171130; CN 201780074202 A 20171130; EA 201991015 A 20171130; EP 17817163 A 20171130; IB 2016057193 W 20161130; IL 26699619 A 20190529; JP 2019529989 A 20171130; JP 2022211038 A 20221228; KR 20197018687 A 20171130; MX 2019005979 A 20171130; US 201716464848 A 20171130; US 202117491067 A 20210930